Healthcare Professionals > Urology > Procedures & Treatments > Men's Health  

Men's Health

As the proven leader in prosthetic urology, Boston Scientific is committed to investing in new technologies, new thinking and new ways to deliver continuous innovation in erectile restoration and male stress urinary incontinence therapies across the globe.

Erectile Restoration

AMS 700™ Inflatable Penile Prosthesis

Male Stress Urinary Incontinence

AMS 800™ Urinary Control System

Patients

Resources for patients and their family members to learn more about erectile dysfunction and bladder leakage, explore treatment options and, for U.S. patients, find a local physician.
If you have any questions about reimbursement or just need to speak with one of our customer service representatives, please visit us at the resources page.

Additional Resources

If you have any questions about reimbursement or just need to speak with one of our customer service representatives, please visit us at the resources page.

Talk to a representative

Talk to a representative

Want to learn more about products and services? One of our sales representatives will be happy to contact you.

Button
Get updates

Get
updates

Stay up-to-date with emails on the latest advances, news and innovations.

Button
Visit us on YouTube

Visit us
on YouTube

Get in-depth information on procedures, products and patient resources, featuring “before and after” stories.

Button
 

References

  1. FDA/PDP D970012-5065.
  2. AMS 700™ with MS Pump™ Penile Prosthesis Product Line Instructions for Use. American Medical Systems, Inc. 2016.
  3. Spectra™ Concealable Penile Prosthesis Instructions for Use. American Medical Systems, Inc. 2017.
  4. Trost L, Elliott DS. Male stress urinary incontinence: a review of surgical treatment options and outcomes. Adv Urol. 2012;2012:287489.
  5. Data on file with Boston Scientific.
  6. Welk BK, Herschorn, S. The male sling for post-prostatectomy urinary incontinence: a review of contemporary sling designs and outcomes. BJU Int. 2012 Feb;109(3):328-44.
Top